Unrelated donor leukocyte infusions to treat relapse after unrelated donor bone marrow transplantation (Q34573989)

3 August 2017

1 reference

title

Unrelated donor leukocyte infusions to treat relapse after unrelated donor bone marrow transplantation (English)

1 reference

3 August 2017

David L Porter

1 reference

3 August 2017

Jose Leis

1 reference

3 August 2017

publication date

1 January 2002

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

9-17

1 reference

Remission of relapsed leukaemia during a graft-versus-host reaction. A "graft-versus-leukaemia reaction" in man?

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190210202

Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190210202

Treatment of relapse after allogeneic bone marrow transplantation with unmanipulated G-CSF-mobilized peripheral blood stem cell preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190210202

Novel approaches to allogeneic stem cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190210202

Adoptive cell-mediated immunotherapy with interleukin-2 (IL-2) for relapsing lymphoblastic crisis following mismatched unrelated bone marrow transplantation in a chronic myelogenous leukemia patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190210202

Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190210202

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190210202

Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190210202

Donor leukocyte infusions in acute lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190210202

Donor leukocyte infusions for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190210202

Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190210202

Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion for recurrent chronic myeloid leukemia after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190210202

Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190210202

Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190210202

21 January 2018

Identifiers

DOI

10.1080/10428190210202

1 reference

3 August 2017

1 reference